RefleXion Medical
RefleXion is developing the first biology-guided radiotherapy system, a significant change in strategy from single tumor therapy to the ability to one day treat multiple tumors in the same treatment session in cancers that have metastasized. Currently, the RefleXion X1 machine is cleared for the delivery of stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT). The company is also developing BgRT, which incorporates positron-emission tomography (PET) imaging data to enable tumors to continuously signal their location. The BgRT technology will synchronize these data with the linear accelerator to direct radiotherapy to tumors with subsecond latency.
Domain
reflexion.com
Country
United StatesIndustry
BiotechnologyEmployees
251-500
Last Funding
$105.0M
Founded
2008
Tech Stack (35 technologies)
Frequently Asked Questions
What technologies does RefleXion Medical use?+
RefleXion Medical uses 35 technologies including AOS, AccessiBe, Bootstrap.
What industry is RefleXion Medical in?+
RefleXion Medical operates in the Biotechnology industry.
Where is RefleXion Medical based?+
RefleXion Medical is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026